About Index Trending news
Analyze
Pricing
Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc.

Work at Eiger BioPharmaceuticals, Inc.? Add yourself to this profile

Eiger BioPharmaceuticals, Inc.

Eiger is a biopharmaceutical company developing new antiviral agents againstnovel targets in the treatment of hepatitis.
Edit Profile
More info

Elsewhere

Contributors to this profile

Companies in the same industry

Alimera Sciences Alimera Sciences KannaLife Sciences KannaLife Sciences Aerie Pharmaceuticals Aerie Pharmaceuticals Cellectis Cellectis molecular assemblies molecular assemblies Hyasynth Bio Hyasynth Bio Chantest Chantest FlowMetric FlowMetric AFFiRiS AG AFFiRiS AG Oculis Oculis

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2
Add info
04 Jan 2017
$25,000,000
Post-IPO debt
Oxford Finance Corporation

Eiger Biopharma Completes 25 Million Debt Financing With Oxford Finance

biospace
29 Apr 2016
$3,000,000
Venture capital

SEC FORM D

sec